Biogen Inc. buy Royal Bank of Canada
Start price
09.02.26
/
50%
€167.00
Target price
09.02.27
€197.12
Performance (%)
-3.40%
Price
30.04.26
€161.32
Summary
This prediction is currently active. With a performance of -3.40%, the BUY prediction for Biogen Inc. by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 09.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 0.273% | 0.273% |
| iShares Core DAX® | 0.985% | 8.314% |
| iShares Nasdaq 100 | 2.067% | 16.765% |
| iShares Nikkei 225® | 2.270% | 15.605% |
| iShares S&P 500 | 1.043% | 11.077% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen (NASDAQ:BIIB) had its price target raised by analysts at Royal Bank Of Canada from $217.00 to $233.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat